CHICAGO, Sept. 2 (UPI) -- Two studies say brachytherapy -- radiation seed implants -- is a superior treatment for early-stage prostate cancer, officials at a Chicago non-profit say.
LONDON, April 27 (UPI) -- Vitamin D cut prostate specific antigen levels, used to mark the seriousness of prostate cancer, by some 50 percent in some subjects, British researchers said.
DUNMORE, Pa., Jan. 2 (UPI) -- A family history of prostate cancer has no impact on treatment outcomes of patients treated with brachytherapy, or seed implants, a U.S. researcher said.
DENVER, June 26 (UPI) -- U.S. men diagnosed with prostate cancer made initial treatment decisions based on fear and uncertainty and had little interest in second opinions.
WASHINGTON, Aug. 15 (UPI) -- Testing for an activated Stat5 protein in prostate tumors predicts whether the cancer will become more aggressive and life threatening, U.S. researchers say.
MINNEAPOLIS, April 1 (UPI) -- U.S. researchers said men who have radiation therapy for prostate cancer have a 70 percent higher risk of rectal cancer than men who have surgery instead.
ATLANTA, Oct. 4 (UPI) -- Prostate cancer patients from lower income brackets are more often unhappy with their treatment decision than patients from higher income brackets.
SEATTLE, Aug. 23 (UPI) -- U.S. scientists have discovered a key driver behind the progression of prostate cancer that could be targeted for future treatments.
ROCKVILLE, Md., Dec. 2 (UPI) -- A new U.S. government study recommended Monday that physicians not test men routinely for prostate cancer because the public health benefit of such testing has not been established.
DURHAM, N.C., Jan. 30 (UPI) -- A new study in its early phase suggests a cancer vaccine made with prostate cancer patients' own cells is safe and effectively triggers an immune system attack on the tumor. Dr. Johannes Vieweg of Duke University Medical Center tested the experimental vac
